Aptus Biosciences is a biotechnology start-up focused on developing diagnostic solutions for neurology, oncology, cardiology, infectious diseases, and women’s health.
The company’s innovative platform utilizes chemically modified DNA aptamers to create novel molecules poised to revolutionize early diagnosis and prognosis of disease.